NEW YORK and LONDON, March 1, 2016
Akari Therapeutics (NASDAQ: AKTX), an emerging growth, development-stage biopharmaceutical company, announced today that Gur Roshwalb, M.D., Chief Executive Officer, will present and participate in a question-and-answer session at the Cowen and Company 36th Annual Health Care Conference in Boston on Wednesday, March 9, 2016, at 11:20 a.m. ET.
